{"name":"Exela Pharma Sciences, LLC.","slug":"exela-pharma-sciences-llc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMingFBVV95cUxPak9JTl9JN2s0dDlBYWYzOHFrT3o3NjB4anBJNG9mQmZfUTFxZFNoU0d6dDlFS2p1bWRxQTlJVmZ0N3V2bjB3Y2ZjSjN0c1RHSGpFUXJzUXQ5R21OTDdBRGlCS1ZDY1VGbVJVSktZWFgxWTZyNExWek52bFV5SE5SbWVMdFpteTdpR3p6bE9OTl92UTlVQ25yNlFqRnFZZ9IBVkFVX3lxTE91VEdjWWMwRWpWTFBtOUd0N0oyT3ZEYVEwZ29GaFdtMGxKRVpub2tGM3dZNzV2Yk1ReWM3bHZYZHIzWUdtVFZodHFrd2Y4TFk5bHkwVE1n?oc=5","date":"2025-10-21","type":"trial","source":"Law360","summary":"Nexus Can't Pursue IP Dropped Before Trial, Del. Judge Says - Law360","headline":"Nexus Can't Pursue IP Dropped Before Trial, Del. Judge Says - Law360","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxONXVtZDY5NGpMRGVObUZZaFBiRXhLUk5lS0ZUY0I4MFI4YUVOUDBxMnB5bVB5V0J1c3VEZVdGR1gyc0dvci1rendKRkExMDlEWE8yZ3k0ei1PQjUzeXNlUk80Q0g5cVJSSUxNdWxubjhhYWIzVXhsdkUyQ2hHdEVTVENpaDdlVXZpdmVtTjdfMXVJLTNZdmpIcS1kT23SAVZBVV95cUxQR003YWswQkUzSTdCS1lHQWdvdnZPQ2J3bFlwWjFFLWU3TWVpUW1tUnd3SHF0ZzkxX3BseEJPMXBjWnhOdE9icFgyRUFoU1MySFdaVk9xZw?oc=5","date":"2025-10-16","type":"trial","source":"Law360","summary":"Nexus Wants New Trial After Exela Cleared In $89M IP Case - Law360","headline":"Nexus Wants New Trial After Exela Cleared In $89M IP Case - Law360","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxObVFMSnlPTHhUSGU4WldVU0V4cWpIRFJUdkZDM0dIUXBjVExxaFhvamphdjRFTXRSdEJ6dnZ5YUEyODcyNjdQNHZvbXhUU09TVzBfWUdtVHZjQ3dUMGlrZW5fTTNmWW04cTJlRkVKMWdycGlwbmtIUE93TTROVmM5eXNZMHh0RDB0V0kxQ3dEWFNNbUtlRktpVDRRT3M?oc=5","date":"2025-09-02","type":"trial","source":"Bloomberg Law News","summary":"Exela Wins Jury Trial Over Nexus Patents for Ephedrine Shot - Bloomberg Law News","headline":"Exela Wins Jury Trial Over Nexus Patents for Ephedrine Shot","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinwFBVV95cUxPYWtsLUhZQkttN3NKMlJuWm5QOWwxY0Z6YmlPWUp2cVZBZ280bW1tTjdFS0R4bkN4UFZVTW14UDZGNkVrTU5RWFBiUy1lZzExV0JyZUxTanduck1hTDNUTS1tVW83Vmp0ZVdLemJXTXp2RExFUnlYYWxQV205Skx3UVZjcG42eFJCT2k1dkRfeTFPcllSS0p6V1lUcXhnMFk?oc=5","date":"2023-02-07","type":"pipeline","source":"Bloomberg Law News","summary":"Exela Sues Nivagen, Asking Court to Block Launch of Elcys Copy - Bloomberg Law News","headline":"Exela Sues Nivagen, Asking Court to Block Launch of Elcys Copy","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMif0FVX3lxTE5ZdFFOZzdxaVlvWnFKOGRLYUgteUctSzVmeGJKSUU4SnRQRDlaZ2h0Rnk2Xy1hd1ZVZG5IS0tLQlpUOENwSHZzTXR4WXFCTzBjSmVNTVIyM1BPOUVhbzdUV1U2RW51RlVna1pxYW9ycG90RTFTMTJTQi1IZVZmUHPSAZMBQVVfeXFMTzFvalZ0Rl9jNHB3UHU5M3Z4TllJYUs2VlJPbGxnZnhQQ2pKcWY5RG5xTDVpaW52Wm5PUGE4WVZFQzZmVy1na1JkLVZhQWI4NzNvVjdNNE1jcUZidWt2ZW9uOTVWMlNjZU04b3g2Zmx1MkV5NlFqcXlhcy1LWEJvY2RwVWNSbExLOFotSDhIOV9LTWdR?oc=5","date":"2022-11-28","type":"pipeline","source":"wpxi.com","summary":"Exela Pharma Sciences, LLC Expands Voluntary Nationwide Recall of Sodium Bicarbonate Injection, USP, 8.4%, 50 mEq/50 mL Vial, 20-Count Carton due to Vial Breakage UPDATED November 28, 2022 - wpxi.com","headline":"Exela Pharma Sciences, LLC Expands Voluntary Nationwide Recall of Sodium Bicarbonate Injection, USP, 8.4%, 50 mEq/50 mL ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixwFBVV95cUxOWUo2M2lVSjEwY2JYcmhodGdDRlZhbGdFbGV6ZUE2N1F0dW1OUHNBdGlKdHNUdmRQcEVDTWIweEVDalVWYjNqXzZheUNQT0c5VGxld1Z4LTAzRVZEdlJWSld4UlR4WHRDMkhqRDU3YUN5ckhvbWxqZnE0Z1VUTTdPbzB6SENnRTRpaXVRbzluVU5nandYMEVNMWpWZ2VwZTlMMkNPelZtRHBoZlhyb3JFYTZmU0x5Nkd0cURodjRwQ1hseUVydXlN?oc=5","date":"2022-10-14","type":"pipeline","source":"Medical Professionals Reference","summary":"Reports of Vial Breakage Prompt Recall of Sodium Bicarbonate Injection - Medical Professionals Reference","headline":"Reports of Vial Breakage Prompt Recall of Sodium Bicarbonate Injection","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi6AFBVV95cUxPYmNrbllLUjVxZlI4TWRLTlRDbjlIenEyWGVXUi0tS0FtdlowY2xhYzlqUjNOS0lzbjN1YVJ6QmNQcGdXLTJ4R29GclNGdjJrUlNTZFVwcjZ5eFlyLXZTakJfVVBnbmNGVHdJT1hLNzcxaFUyMFMxT3BSaWRXREozM2liLXR6dFhJUXZrNkViVm9YRHNTR1YwZW9FQzVibkpWME9tMlF5UFVtYjF5bmppS0NGMjhteDRKYi1JU2dOdEJHOHp6ZzdGeGVrc3hGaFdQX1E2Q1dYMW9yaFcxZFE1Znp6NlNmNVll?oc=5","date":"2021-09-09","type":"pipeline","source":"Riverside Health","summary":"Riverside Health System Invests to Expand U.S. Drug Manufacturing Through Exela Pharma Sciences, LLC® - Riverside Health","headline":"Riverside Health System Invests to Expand U.S. Drug Manufacturing Through Exela Pharma Sciences, LLC®","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMioAJBVV95cUxPMFotUjB6bXpGaDNXb1dQLXo0dkxQdS1NckdNdmRiUmxWVUdNaDY4RkIySGpwblNnSGFUeUlIdmtIbFlROG1DVlpWaGtDZHlIQ1VRZzlPRzJuaVRrRDJSRXVVdGZrSEpaeDJnSkIyLUlOdXpuYVpiNDNLWENPeGZJRnlZNmVueW5lX1J6azJFMGtTUjVOSFMtTmMzVDlTWVV1VUlCSE1aaUZvVkcyXzRPTVUyMl9xNG5xSXJXb0dWNEZvOV9nbnlKQmVyZFBvN1dPUVFVVmtSYWRmdU1xcXBQUnA1SUhmYURURlhMOHlzeURERklhSm11OUk2b3JyUjRhRXFFb2dHWVd6a0wwVjkzd0s1MldUZTdQR0EydEN3TGs?oc=5","date":"2021-09-08","type":"pipeline","source":"Business Wire","summary":"Premier Inc. and 11 Leading Health Systems Invest in Exela Pharma Sciences to Secure and Support U.S.- Based Drug Supply and Manufacturing - Business Wire","headline":"Premier Inc. and 11 Leading Health Systems Invest in Exela Pharma Sciences to Secure and Support U.S.- Based Drug Supply","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiwFBVV95cUxPSkRnZFVUbmdjMnRWUGh1QUpISnBZXzVuUzlUQWhBWTF2RDlVVVpSOGJLUTlfOHNJalE4b2J1ZFUtZjdyajRJRHRlMDQ5bWs0RzFrWXBGNXBYQVRmNXJXbUpFX1pLdm1JM214V0FmUlREUUM0UEJuWmg5czY5LVhYOEk3ekFrN1JiNmc4?oc=5","date":"2013-06-06","type":"deal","source":"CoStar","summary":"News | Exela Pharma Sciences Buys Lenoir Office Bldg. - CoStar","headline":"News | Exela Pharma Sciences Buys Lenoir Office Bldg.","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}